WOODLAND PHARMACY LTDActive

Company number 05325552Private limited companyIncorporated 2005

Key figures

£1,485,257-5.0%
Net assets 2024/25
-2.2%
Average annual change 2019/20–2024/25
0500 k1 m1.5 m2 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, WOODLAND PHARMACY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand1,706,7881,557,2481,622,291590,441548,627
Total assets2,220,6532,087,7122,038,3911,781,9181,732,997
Total liabilities474,990290,395241,424226,315252,751
Net assets / total equity1,749,2891,800,2171,800,0181,562,6221,485,257
Average number of employees44555

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: WOODLAND PHARMACY LTD

Company

WOODLAND PHARMACY LTD is a private limited company registered with Companies House under company number 05325552. It was incorporated on 6 Jan 2005. Its status is active. The registered office is in Middlesex (UB1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £1,485,257, down 5% on the previous year. Cash at bank and in hand was £548,627. Total assets were £1,732,997 and total liabilities £252,751. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 13 Nov 2026.